Delivery Order SPE2DB20D3103-SPE2DB24FP6V0
Award Date
7/26/24
Potential Completion Date
8/16/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Veklury (Remdesivir) 100 mg vials. The contract, valued at $13,618.40, is a firm fixed-price delivery order with a period of performance through June 24, 2024. Amerisourcebergen, through its Corporate Office division, leverages its extensive pharmaceutical supply chain to efficiently deliver critical medical products to the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (remdesivir) 100 mg vials. The contract, valued at $15,848.80, is a firm fixed-price delivery order that runs through March 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the antiviral drug VEKLURY (Remdesivir) in 100 mg vials. The $2,042.76 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of VEKLURY (remdesivir) 100 mg vials to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order, valued at $2,383.22, has a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 2025. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of VEKLURY (remdesivir) 100 mg vials. The firm fixed price contract has a potential value of $27,236.80 and a completion date of March 5, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, which serves as...
This is a delivery order award under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) valued at $30,112.72 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VEKLURY (remdesivir) 100 mg vials, a critical antiviral medication. The award has an ultimate completion date of April 4, 2025 and uses a firm fixed price pricing type. This order is part of a larger $999,999,999 IDC that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a ceiling value of $8,511.50 and an ultimate completion date of September 24, 2024. The award is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg VEKLURY (remdesivir) vials. The contract has a ceiling value of $13,618.40 and an ultimate completion date of September 20, 2024. It is a firm-fixed-price contract and does not utilize any set-aside designations. AmerisourceBergen, through its Corporate Office Division, has been awarded numerous federal contracts and...
The U.S. Defense Logistics Agency (DLA) awarded a $6,803.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. for the supply of 100 mg Veklury (Remdesivir) vials. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a broad range of pharmaceutical products and medical supplies for military healthcare programs. The contract has no set-aside designation, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,754.64, is for the supply of Veklury (Remdesivir) 100 mg vials, a critical medication used to treat COVID-19. The contract is a firm fixed-price delivery order with a completion date of February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...